7 results found. Viewing page 1 of 2.
Go to page
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...
Continue Reading...
A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...
Continue Reading...
Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...
Continue Reading...
The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...
Continue Reading...
The University of Hawaii Cancer Center has published novel research on the BAP1 genetic mutation found in an estimated 10% of patients with mesothelioma with the goal of better understanding the unique traits of carriers of the mutation. Michele ...
Continue Reading...
7 results found. Viewing page 1 of 2.
Go to page